Madhu K. Natarajan, MD, MSc

Original Contribution

Impact of Routine In-Hospital Assessment of Low-Density Lipoprotein Levels and Standardized Orders on Statin Therapy
in Patient

08/01/2008

Mayraj Ahmad , MD;

James L. Velianou , MD;

Madhu K. Natarajan , MD, MSc;

Jon David Schwalm , MD, MSc;

Elevated cholesterol is a well-established major cardiac risk factor for the development of coronary artery disease (CAD). Multiple randomized controlled trials have clearly demonstrated that lowering low-density lipoprotein (LDL) levels with...

Elevated cholesterol is a...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Avoiding S3 Valve Over-Sizing by Deployment Balloon Over-Filling: Impact on Rates of Permanent Pacemaker and Other Procedural Complications During TAVR

12/27/2017

James L. Velianou , MD;

Madhu K. Natarajan , MD, MSc;

Catherine Kreatsoulas , PhD;

Richard Whitlock , MD, PhD;

Dominic Parry , MD;

Victor Chu , MD;

Amanda Smith , RN, PhD;

Tej Sheth , MD, FRCPC, FACC;

Patients with annular areas just above nominal Sapien 3 (S3) valve areas are at increased risk of over-sizing if a larger valve is implanted. We therefore evaluated the rate of permanent pacemaker implantation associated with avoiding...

Patients with annular areas just...

12/27/2017

Journal of Invasive Cardiology

Single-Center Study

Rates of Intraprocedural Adverse Events and Supportive Interventions During Percutaneous Coronary Interventions: A Single-Center, Retrospective Analysis

07/07/2021

Ryan Quinn , MD, FRCPC;

Ahmad Alshatti , MD, MRCP;

Matthew Sibbald , MD, FRCPC, MSc, PhD;

Madhu K. Natarajan , MD, MSc;

Hussain Alzayer , MD;

Aiman Alak , MD;

In PCI literature, major adverse events such as stroke, MI, bleeding, or death have been well studied. However, no studies have evaluated the types and rates of adverse events requiring intraprocedural supportive interventions that occur...

In PCI literature, major adverse...

07/07/2021

Cath Lab Digest